IRIS - Res&Arch Institutional Research Information System - Research & Archive

MECOCCI, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.094
NA - Nord America 9.048
AS - Asia 1.920
SA - Sud America 24
Continente sconosciuto - Info sul continente non disponibili 17
AF - Africa 5
OC - Oceania 3
Totale 20.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.012
IT - Italia 2.545
IE - Irlanda 1.800
UA - Ucraina 1.526
SE - Svezia 1.215
HK - Hong Kong 754
VN - Vietnam 723
FI - Finlandia 413
RU - Federazione Russa 385
FR - Francia 322
DE - Germania 316
CN - Cina 213
GB - Regno Unito 182
CH - Svizzera 104
AT - Austria 96
TR - Turchia 77
PL - Polonia 48
BE - Belgio 32
CA - Canada 30
NL - Olanda 30
UZ - Uzbekistan 29
GR - Grecia 23
IR - Iran 23
KR - Corea 20
RO - Romania 20
MY - Malesia 19
EU - Europa 17
LB - Libano 16
SG - Singapore 15
BR - Brasile 14
IN - India 12
BG - Bulgaria 8
CZ - Repubblica Ceca 8
PH - Filippine 7
ES - Italia 6
JP - Giappone 5
MX - Messico 4
SK - Slovacchia (Repubblica Slovacca) 4
AU - Australia 3
CL - Cile 3
EC - Ecuador 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
IQ - Iraq 2
PE - Perù 2
AL - Albania 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
JM - Giamaica 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
SA - Arabia Saudita 1
SV - El Salvador 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 20.111
Salva come PNG Salva come JPEG
Città #
Chandler 1.965
Dublin 1.798
San Mateo 896
Jacksonville 836
Hong Kong 753
Dong Ket 722
Altamura 521
Medford 467
Princeton 463
Lawrence 397
Wilmington 344
Perugia 293
Andover 266
Ann Arbor 230
Beijing 168
Des Moines 132
Saint Petersburg 121
Rome 110
Norwalk 100
Redmond 94
Falls Church 83
Boardman 75
Izmir 74
Milan 73
San Paolo di Civitate 70
Helsinki 65
Los Angeles 64
Vienna 61
Woodbridge 60
Houston 53
Ashburn 52
Redwood City 46
New York 43
Dearborn 34
Brussels 31
Terni 29
Florence 26
Lappeenranta 26
Moscow 26
Auburn Hills 25
Bologna 25
Kraków 25
Prato 25
Padova 23
Ardabil 22
Palermo 22
Monmouth Junction 21
Toronto 20
Den Haag 19
Bari 18
Chicago 17
Frankfurt Am Main 16
Civitavecchia 14
Caserta 13
Torino 13
Brescia 11
Napoli 11
Shanghai 11
Turin 11
Verona 11
Naples 10
Assisi 9
Cornigliano 9
Lausanne 9
Lugano 9
Venezia 9
Fairfield 8
Paris 8
San Diego 8
Pescara 7
Seattle 7
Seoul 7
Sesto Fiorentino 7
Tappahannock 7
Udine 7
Bergamo 6
Collazzone 6
Genoa 6
Tyresö 6
Vernio 6
Castelnuovo Rangone 5
Concesio 5
Dallas 5
Kuala Lumpur 5
Livorno 5
Nanning 5
Parma 5
Philadelphia 5
Pisa 5
Ravenna 5
Rovereto 5
Treviso 5
Vicenza 5
Vicovaro 5
Viterbo 5
Bolzano 4
Cagliari 4
Catania 4
Fabriano 4
Giugliano In Campania 4
Totale 12.286
Salva come PNG Salva come JPEG
Nome #
Validazione della versione italiana della Geriatric Depression Scale a 5 item in tre differenti setting assistenziali 1.301
I disturbi comportamentali “clinicamente rilevanti” nella demenza vascolare, nella demenza a corpi di Lewy e nella demenza di Alzheimer: studio su 921 pazienti anziani. 188
Musicalmente: sviluppo di un paradigma per la valutazione dell’efficacia della musicoterapia nel trattamento della demenza 137
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 106
The brain of the elderly between normality and pathology: Techniques and technologies for the evaluation 102
Antiossidanti plasmatici e longevità: studio su centenari sani 101
Fracture prevention service to bridge the osteoporosis care gap 101
Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics. 99
Validation study of the Italian Addenbrooke’s Cognitive Examination Revised in a young-old and old-old population 98
Antioxidants for the treatment of mild cognitive impairment. (Review) 98
Platelet MAO-B activity and vitamin B12 in old age dementias. 96
Oxidative stress and dementia: new perspectives in AD pathogenesis. 93
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. 87
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 85
Alterazioni biochimiche nel cervello di soggetti con ipertensione cronica e in pazienti con demenza di Alzheimer in fase precoce valutate mediante risonanza magnetica spettroscopica 84
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 83
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 83
Dementia, depression and parkinsonism: A frequent association in the elderly. 82
Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer's dementia 82
The orthogeriatric management: an inseparable duo to foster appropriate care 82
Axonal injury within language network in primary progressive aphasia 81
Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts 80
Predicting progression of Alzheimer's disease using ordinal regression 78
La risonanza magnetica spettroscopica differenzia il Mild Cognitive Impairment dal normale invecchiamento cerebrale 78
The effects of aging and endurance exercise on cardiovascular performance in healthy elderly: a review of the literature. 78
Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer’s disease 77
Approccio diagnostico ai disturbi cognitivi in corso di patologie somatiche nell’anziano. 77
Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study 76
Pharmaceutical treatment of cognitive disorders in Alzheimer's disease. 76
Insight, cognition and quality of life in Alzheimer's disease. 76
Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity 76
Vitamin D supplementation with calcidiol and cholecalciferol among oldest-old persons 76
Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation 75
Attività dell'Aconitasi Mitocondriale nella demenza di Alzheimer e nel Mild cognitive impairment 75
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 73
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis. 72
Antioxidants micronutrients in the prevention of age-related diseases: focus on Alzheimer’s disease 72
Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease 72
Normative data for the ACE-R in an Italian population sample. 72
Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease. 72
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. 72
Generalizability of the Disease State Index Prediction Model for Identifying Patients Progressing from Mild Cognitive Impairment to Alzheimer's Disease. 71
Cognitive Impairment Is the Major Risk Factor for Development of Geriatric Syndromes during Hospitalization: Results from the GIFA Study 71
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 70
Common genetic variants influence human subcortical brain structures. 70
Metabolic syndrome and risk of dementia in older adults. 70
Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. 70
Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. 70
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 69
Circulating Proteomic Signatures of Chronological Age 69
Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort 68
The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months 68
An ontology-based personalization of health-care knowledge to support clinical decisions for chronically ill patients 68
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. 68
Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status : Results from the Zincage Project. 68
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey 67
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. 67
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 67
Alzheimer's disease: clinical trials and drug development. 67
Deterioramento cognitivo e sviluppo di sindromi geriatriche durante il ricovero ospedaliero: risultati dello studio GIFA 67
Blood pressure and functional aspects of the aging brain. 67
Nutraceuticals in cognitive impairment and Alzheimer's disease 67
Altered mitochondrial membrane fluidity in AD brain. 66
The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults 66
FASTKD2 is associated with memory and hippocampal structure in older adults 65
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 64
Le demenze vascolari 64
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 64
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 64
Topics in clinical pharmacology: cardiovascular and diabetes mellitus. 63
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 63
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America 63
Elevati livelli plasmatici delle forme di vitamina E e riduzione del rischio di malattia di Alzheimer in età avanzata 62
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. 61
Area-specific differences in OH8dG and mtDNA4977 levels in Alzheimer disease patients and aged controls. 61
High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians. 60
Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle 60
Paziente anziano, paziente geriatrico e medicina della complessità. Fondamenti di Gerontologia e Geriatria (III edizione) 60
Antioxidant agents in Alzheimer’s disease 60
Gli effetti dell’anemia e dell’emotrasfusione sugli indicatori clinici nel paziente anziano con frattura di femore. 60
Validation of the five-item geriatric depression scale in elderly subjects in three different settings. 60
Age and sex influence on oxidative damage and functional status in human skeletal muscle. 60
Anticholinergic burden and functional status in older people with cognitive impairment: Results from the ReGAl project 60
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment 59
Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. 59
The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study 58
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 58
Antibiotic use and associated factors in a large sample of hospitalised older people 58
AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. 58
Paziente anziano, Paziente geriatrico 57
Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity. 57
Antioxidant profile and early outcome in stroke patients. 57
Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. 57
Il ruolo dei fattori di rischio vascolare nei sottotipi di mild cognitive impairment. Risultati del progetto ReGAl 56
Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder 56
Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease 56
Lower serum levels of IL-13 is associated with increased carotid intima-media thickness in old age subjects 56
H-1-MR spectroscopy differentiates mild cognitive impairment from normal brain aging 56
Neuropsychological assessment of the severely impaired elderly patient: validation of the Italian short version of the Severe Impairment Battery (SIB). 55
Influenza della comorbilità e dello stato cognitivo sulle attività strumentali della vita quotidiana nei soggetti con Mild Cognitive Impairment Amnesico (aMCI): risultati del Progetto ReGAl. 55
Totale 8.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019147 0 0 0 0 0 0 0 0 0 0 100 47
2019/20202.018 81 46 266 35 273 74 265 75 491 159 60 193
2020/20214.152 41 219 181 236 1.067 236 250 31 450 334 316 791
2021/20223.852 158 685 128 245 137 70 71 1.127 121 121 446 543
2022/20236.920 501 1.373 76 526 534 697 89 342 2.429 60 205 88
2023/20242.004 204 328 158 97 29 26 478 130 426 124 4 0
Totale 21.415